Welcome to TexRAD Limited - Risk, Prognosis and Treatment Response

TexRAD is a novel sophisticated imaging risk stratification tool that analyses clinical diagnostic images, both heterogeneity analysis and texture analysis. TexRAD is a software application that analyses textures, detecting and measuring 'tumor complexity' from these images. TexRAD provides additional clinical information vital to optimising cancer care pathways, supporting improved patient outcomes and effective resource utilisation.

Cancer Treatments can be tailored to patients needs. It is hoped that TexRAD will potentially support early diagnosis in other diseases and long term conditions such as dementia and other long term conditions, enabling early intervention and reducing disease progression.

TexRAD is not an FDA or CE approved medical device.  It is currently a Research software used entirely at the owner's own risk, click here for full disclaimer.

NAME*

COMPANY*

EMAIL*

TELEPHONE NUMBER

MESSAGE*

Enter Captcha Code*